Literature DB >> 15981301

Evaluation of antimicrobial activities of several mannich bases and their derivatives.

Halise Inci Gul1, Fikrettin Sahin, Mustafa Gul, Suzan Ozturk, Kadir Ozden Yerdelen.   

Abstract

The aim of this study was to evaluate the antimicrobial activities of several Mannich bases and their derivatives against pathogenic bacteria and fungi. 3-Dimethylamino-1-phenyl-1-propanone hydrochloride (Ig1) as mono-Mannich base, bis(beta-aroylethyl)methylamine hydrochlorides (B1, B5) as bis-Mannich bases, 3-aroyl-4-aryl-1-methyl-4-piperidinol hydrochlorides (C1, C5) as piperidinol derivatives, which are structural isomers of bis-Mannich bases, N,N'-Bis(3-dimethylamino-1-phenylpropylidene)hydra zine dihydrochlorides (D1) as azine derivative of mono-Mannich base Ig1, and some representative quaternary derivatives (Ig4 and C6), which are quaternary derivatives of Ig1 and C1, respectively, have been synthesized. Aryl parts were phenyl in B1 and C1, and 2-thienyl in B5 and C5. Bis-Mannich bases and quaternary Mannich bases were found to be effective antifungal derivatives. Quaternary mono-Mannich base Ig4 has shown twice the amount of higher antifungal potency against the human pathogenic fungus Microsporum canis compared with the reference drug amphotericin-B and it had equal potency against many other fungi species pathogenic in humans and plants. Ig4 was effective against Staphylococcus aureus among the bacteria tested. Preparation of bis-Mannich bases and qua ternization procedure seemed suitable chemical modifications to prepare effective antifungal compounds. Especially quaternary derivatives Ig4, and to some extent C6, seem to be model compounds to develop new antimicrobial agents for further studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981301     DOI: 10.1002/ardp.200400962

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  9 in total

1.  Synthesis of 1-Aryl-3-phenethylamino-1-propanone hydrochlorides as possible potent cytotoxic agents.

Authors:  Ebru Mete; Halise Inci Gul; Cavit Kazaz
Journal:  Molecules       Date:  2007-12-12       Impact factor: 4.411

Review 2.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

3.  N-[2-(4-Bromo-benzo-yl)eth-yl]isopropyl-aminium chloride.

Authors:  Abdullah Aydın; Mehmet Akkurt; Halise Inci Gul; Ebru Mete; Ertan Sahin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-12-10

4.  Synthesis, hematological, biochemical, and neurotoxicity screening of some mannich base hydrochlorides.

Authors:  Karima Lahbib; Iyadh Aouani; Hafedh Abdelmelek; Soufiane Touil
Journal:  Toxicol Int       Date:  2013-09

5.  Synthesis and antifungal evaluation of 1-aryl-2-dimethyl- aminomethyl-2-propen-1-one hydrochlorides.

Authors:  Ebru Mete; Halise Inci Gul; Sinan Bilginer; Oztekin Algul; Mehmet Emin Topaloglu; Medine Gulluce; Cavit Kazaz
Journal:  Molecules       Date:  2011-06-03       Impact factor: 4.411

6.  N-(2-Benzoyl-eth-yl)propan-2-aminium chloride.

Authors:  Abdullah Aydın; Mehmet Akkurt; Halise Inci Gul; Ebru Mete; Ertan Sahin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-11

7.  N-[2-(4-Methyl-benzo-yl)eth-yl]propan-2-aminium chloride.

Authors:  Abdullah Aydın; Mehmet Akkurt; Halise Inci Gul; Ebru Mete; Ertan Sahin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-15

8.  Exploration of piperidinols as potential antitubercular agents.

Authors:  Areej Abuhammad; Elizabeth Fullam; Sanjib Bhakta; Angela J Russell; Garrett M Morris; Paul W Finn; Edith Sim
Journal:  Molecules       Date:  2014-10-10       Impact factor: 4.411

9.  Mannich base limits Candida albicans virulence by inactivating Ras-cAMP-PKA pathway.

Authors:  Satish Kumar Rajasekharan; Chakkaravarthi Kamalanathan; Vinothkannan Ravichandran; Arvind Kumar Ray; Ann Susan Satish; Sucharitha Kannappan Mohanvel
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.